|
|
||||||||
The Journal of Immunology, Vol 151, Issue 12 6712-6722, Copyright © 1993 by American Association of Immunologists
ARTICLES |
KS Hathcock, H Hirano, S Murakami and RJ Hodes
Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
CD44 expression and the functional capacity for CD44-dependent binding of hyaluronic acid (HA) were analyzed on unstimulated B cells and on B cells stimulated with a variety of polyclonal B cell activators. Whereas essentially all LPS-activated and anti-IgD-dextran-activated B cells and a subpopulation of IL-5-activated B cells expressed increased levels of cell surface CD44 relative to unstimulated B cells, only IL-5- activated CD44hi B cells constitutively bound to FITC-conjugated hyaluronic acid (FITC-HA). Preincubation of LPS or anti-IgD-dextran- activated B cells with the CD44-specific mAb IRAWB14.4 (IRA) induced a high degree of FITC-HA binding in these populations; preincubation of unstimulated B cells with this CD44-specific mAb induced minimal FITC- HA binding. In contrast, preincubation with mAb IRA failed to induce FITC-HA binding by the IL-5-activated CD44lo B cell subset. Neither the amount of constitutive FITC-HA binding nor the level of IRA-inducible FITC-HA binding correlated simply with the overall level of CD44 expressed by the different B cell populations. Biochemical analysis of immunoprecipitated CD44 molecules revealed that relative to CD44 isolated from all other populations examined, CD44 isolated from IL-5- activated B cells was of a lower molecular weight. Treatment with N- Glycanase eliminated this observed difference in molecular weight, indicating that it reflected differences in N-glycosylation of CD44 on activated B cells. Polymerase chain reaction analysis of amplified cDNA showed that each B cell population expressed a common dominant CD44 mRNA. These findings suggest that post-translational modification of CD44 and/or differential association of CD44 with other cellular components plays a critical role in activation-specific ligand binding by CD44.
This article has been cited by other articles:
![]() |
R. Song, Y.-W. Kim, B.-K. Koo, H.-W. Jeong, M.-J. Yoon, K.-J. Yoon, D.-J. Jun, S.-K. Im, J. Shin, M.-P. Kong, et al. Mind bomb 1 in the lymphopoietic niches is essential for T and marginal zone B cell development J. Exp. Med., October 27, 2008; 205(11): 2525 - 2536. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. de Andres, I. Cortegano, N. Serrano, B. del Rio, P. Martin, P. Gonzalo, M. A. R. Marcos, and M. L. Gaspar A Population of CD19highCD45R /lowCD21low B Lymphocytes Poised for Spontaneous Secretion of IgG and IgA Antibodies J. Immunol., October 15, 2007; 179(8): 5326 - 5334. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lesley, I. Gal, D. J. Mahoney, M. R. Cordell, M. S. Rugg, R. Hyman, A. J. Day, and K. Mikecz TSG-6 Modulates the Interaction between Hyaluronan and Cell Surface CD44 J. Biol. Chem., June 11, 2004; 279(24): 25745 - 25754. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bischof, M. Hofmann, T. N. M. Schumacher, F. A. Vyth-Dreese, R. Weissert, H. Schild, A. M. Kruisbeek, and A. Melms Analysis of Autoreactive CD4 T Cells in Experimental Autoimmune Encephalomyelitis after Primary and Secondary Challenge Using MHC Class II Tetramers J. Immunol., March 1, 2004; 172(5): 2878 - 2884. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Aziz, K. J. Till, M. Zuzel, and J. C. Cawley Involvement of CD44-hyaluronan interaction in malignant cell homing and fibronectin synthesis in hairy cell leukemia Blood, November 1, 2000; 96(9): 3161 - 3167. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nandi, P. Estess, and M. H. Siegelman Hyaluronan Anchoring and Regulation on the Surface of Vascular Endothelial Cells Is Mediated through the Functionally Active Form of CD44 J. Biol. Chem., May 12, 2000; 275(20): 14939 - 14948. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Noorchashm, A. Bui, H.-L. Li, A. Eaton, L. Mandik-Nayak, C. Sokol, K. M. Potts, E. Pure, and J. Erikson Characterization of anergic anti-DNA B cells: B cell anergy is a T cell-independent and potentially reversible process Int. Immunol., May 1, 1999; 11(5): 765 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Esford, A Maiti, S. Bader, F Tufaro, and P Johnson Analysis of CD44 interactions with hyaluronan in murine L cell fibroblasts deficient in glycosaminoglycan synthesis: a role for chondroitin sulfate J. Cell Sci., January 4, 1998; 111(7): 1021 - 1029. [Abstract] [PDF] |
||||
![]() |
L. Mandik-Nayak, A. Bui, H. Noorchashm, A. Eaton, and J. Erikson Regulation of Anti-double-stranded DNA B Cells in Nonautoimmune Mice: Localization to the T-B Interface of the Splenic Follicle J. Exp. Med., October 20, 1997; 186(8): 1257 - 1267. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rafi, M. Nagarkatti, and P. S. Nagarkatti Hyaluronate-CD44 Interactions Can Induce Murine B-Cell Activation Blood, April 15, 1997; 89(8): 2901 - 2908. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Murakami, T. Saho, A. Asari, E. Hino, D. Kasai, Y. Shimabukuro, and H. Okada CD44-Hyaluronate Interaction Participates in the Adherence of T-lymphocytes to Gingival Fibroblasts Journal of Dental Research, August 1, 1996; 75(8): 1545 - 1552. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |